Andreia C. Pereira
Postdoctoral Researcher
Contacts
Office: iCBR, floor 1, room 52
Polo III - Health Sciences Campus
Azinhaga Santa Comba, Celas
3000-548 Coimbra, Portugal
Phone: (+351) 239 480 243
Discord username: Andreia Pereira#3859
Email: acpereira [at] fmed.uc.pt
Twitter: @andreiap
Current project(s)
- Autism Innovative Medicine Studies-2-Trials (AIMS-2-Trials)
- Synaptic networks and personalized medicine approaches to understand neurobehavioural diseases across the life span (PAC MEDPERSYST - POCI-01-0145-FEDER-016428)
- From computational modelling and clinical research to the development of neuroimaging big data platforms for discovery of novel biomarkers (BIGDATIMAGE - CENTRO-01-0145-FEDER-000016)
Keywords
- Autism Spectrum Disorder
- Neurochemistry
- Electrophysiology
- Psychophysics
- Pharmacological neuroimaging
Background
- PhD in Neuroscience, Institute of Psychiatry, Psychology and Neuroscience, King´s College London, United Kingdom
- MSc in Cell and Molecular Biology, Faculty of Science and Technology, University of Coimbra, Portugal.
- BSc in Biology, Faculty of Science and Technology, University of Coimbra, Portugal.
Selected publications
- Qiyun Huang, Andreia C. Pereira, Hester Velthuis, Nichol M. L. Wong, Claire L. Ellis,Francesca M. Ponteduro, Mihail Dimitrov1, Lukasz Kowalewski, David J. Lythgoe, Diana Rotaru, Richard A. E. Edden, Alison Leonard, Glynis Ivin, Jumana Ahmad, Charlotte M. Pretzsch,Eileen Daly, Declan G. M. Murphy, Gráinne M. McAlonan (2022). “GABAB receptor modulation of visual sensory processing in adults with and without autism spectrum disorder”. Science Translational Medicine. DOI 10.1126/scitranslmed.abg7859. link
- Laura A. Ajram, Andreia C. Pereira, Alice M. S. Durieux, Hester E. Velthuis, Marija M. Petrinovic, Grainne M. McAlonan (2019). “The contribution of [1H] magnetic resonance spectroscopy to the study of excitation-inhibition in autism”. Progress in Neuropsychopharmacology & Biological Psychiatry. DOI 0.1016/j.pnpbp.2018.09 . link.
- Andreia Carvalho Pereira, Ines R. Violante, Susana Mouga, Guiomar Oliveira, Miguel Castelo-Branco (2018). ”Medial frontal lobe neurochemistry in Autism Spectrum Disorder is marked by reduced N-acetylaspartate and unchanged gamma-aminobutyric acid and glutamate+glutamine levels”. Journal of Autism and Developmental Disorders. DOI: 10.1007/s10803-017-3406-8 . link